+91 - 830 - 3146878
The purpose of this study was to evaluate the efficacy study of herbomineral drug LAS Capsule in oesophageal cancer patients who were admitted in Lavanya Ayurvedic Hospital & Research Center For Cancer, Hepatitis and AIDS. The study was conducted after getting ethical clearance. Total 06 patients were enrolled in Lavanaya hospital. These patients were suffering only from oesophageal cancer not any other diseases. All patients having medication ayuredic herbomineral drug LAH Capsule for more than one month treatment. After obtaining prior consent form these patients, venous blood samples was collected from the subjects before and after treatment with herbomineral drug LAS 02 Capsule and measured the hematological and biochemical examinations along with tumor size. The results of these study showed that there was significant increased hemoglobin and Platelet count in herbomeneral treated patients as compared with pre treated patients. The ESR and total tumor size was also decreased after treatment with LAS02 drug as compared with pre treated patients. These findings suggested that LAS 02 is most effective medicine for enhanced the hematological parameters along with decreased tumor size in oesophageal cancer patients.
The study was conducted after getting ethical clearance from Institutional human ethic committee. Total 06 oesophageal cancer patients with age (35-75 years) were enrolled in Lavanya Ayurvedic Hospital and Research Center. These patients were only suffering from oesophageal cancer from any organic diseases. After obtaining prior consent form, venous blood samples was collected from the subjects before (pre) and after treatment (post) with herbomineral drug LAS02 Capsule under aseptic condition. The drug was given to these patients for more than months. After collection of blood sample, the measurement of hematological, parameters along with tumor size in pre and post treated patients.
All hematological and biochemistry parameters hemoglobin (Hb), Platelet ESR parameters were measured by fully automatic cell counter analyzer.
Total tumor size were measured by using a CT scan, MRI technique
Resulting data were expressed mean ± SD. Percentage parenthesis was observed between pre vs post treatment with LAS02 drug in hepatitis patients.
There was significant reduction of total tumor size (cm) 40.17% in post treated patients with LAS02 drug in comparison to pre treated patients. VIEW CHART
There was significant reduction of Erythrocyte sedmentation rate (ESR) 19.05 % in post treated patients with LAS02 drug in comparison to pre treated patients. VIEW CHART
There were slightly increased Hb(%),13.0% platelet count 11.0% levels in patient treated group as compared with patient pre treated group.
On the basis of these findings it is suggested that the herbomineral drug LAS 02 capsule is safe and most effective medicine for prevention of oseophageal cancer.
|Parameters||Pre treated Patients (n=6)||Post treated Patients (n=6)|
|Platelet count (cmm)||222000||246500|
|Total tumor size (cm)||38.48||23.02|
The purpose of this study was to evaluate the acute oral toxicity study of LAS02 in female Sprague Dawley rat model. [...]
The purpose of this study was to evaluate the maximum tolerated dose of LAS02 in Sprague dawley female rat. [...]
The aim of this study was to evaluate the maximum tolerated dose of LAS02 in female Sprague Dawley rat. [...]